First report of Candida auris infections from Saudi ArabiaDear Editor, Candida auris is an emerging multidrug resistant pathogen worldwide causing a variety of nosocomial infections and creating a major challenge for infection control and prevention teams [1,2].C. auris infections have been reported in over 20 countries on five continents including Gulf States such as Kuwait, Oman, and UAE [1-8].To our knowledge, we report the first three cases of C. auris infections from Saudi Arabia.From December 2017 to February 2018, blood cultures from 2 patients from the adult intensive care units (AICU) at King Fahad Specialist Hospital-Dammam (KFSHD) and a pleural tissue culture from a patient from AICU at King Faisal Specialist Hospital and Research Center (KFSH-RC) in Riyadh, revealed C. haemulonii by the advanced expert software of Vitek 2 system (BioMerieux, Marcy l'Etoile, France).All 3 strains were resistant to fluconazole with minimum inhibitory concentrations (MIC ≥ 64 g/ml) and 2 strains had elevated MIC to amphotericin B (MIC = 2 g/ml) using YeastOne microdilution broth method (TREK Diagnostics, OH,
No takes yet. Share an insight, caveat, or question.
Abdalhamid et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: